Revvity Shares Outstanding 2012-2026 | RVTY
Revvity shares outstanding history from 2012 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Revvity shares outstanding for the quarter ending June 30, 2026 were 0.112B, a 5.03% decline year-over-year.
- Revvity 2025 shares outstanding were 0.117B, a 5.07% decline from 2024.
- Revvity 2024 shares outstanding were 0.123B, a 1.59% decline from 2023.
- Revvity 2023 shares outstanding were 0.125B, a 1.28% decline from 2022.
|
Revvity Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 117 |
| 2024 | 123 |
| 2023 | 125 |
| 2022 | 126 |
| 2021 | 117 |
| 2020 | 112 |
| 2019 | 112 |
| 2018 | 112 |
| 2017 | 111 |
| 2016 | 110 |
| 2015 | 113 |
| 2014 | 114 |
| 2013 | 114 |
| 2012 | 115 |
| 2011 | 114 |
|
Revvity Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2026-06-30 | 112 |
| 2026-03-31 | 112 |
| 2025-12-31 | 117 |
| 2025-09-30 | 115 |
| 2025-06-30 | 118 |
| 2025-03-31 | 120 |
| 2024-12-31 | 123 |
| 2024-09-30 | 123 |
| 2024-06-30 | 123 |
| 2024-03-31 | 124 |
| 2023-12-31 | 125 |
| 2023-09-30 | 124 |
| 2023-06-30 | 125 |
| 2023-03-31 | 126 |
| 2022-12-31 | 126 |
| 2022-09-30 | 127 |
| 2022-06-30 | 127 |
| 2022-03-31 | 127 |
| 2021-12-31 | 117 |
| 2021-09-30 | 115 |
| 2021-06-30 | 112 |
| 2021-03-31 | 112 |
| 2020-12-31 | 112 |
| 2020-09-30 | 112 |
| 2020-06-30 | 112 |
| 2020-03-31 | 112 |
| 2019-12-31 | 112 |
| 2019-09-30 | 112 |
| 2019-06-30 | 112 |
| 2019-03-31 | 111 |
| 2018-12-31 | 112 |
| 2018-09-30 | 112 |
| 2018-06-30 | 111 |
| 2018-03-31 | 111 |
| 2017-12-31 | 111 |
| 2017-09-30 | 111 |
| 2017-06-30 | 111 |
| 2017-03-31 | 110 |
| 2016-12-31 | 110 |
| 2016-09-30 | 110 |
| 2016-06-30 | 110 |
| 2016-03-31 | 111 |
| 2015-12-31 | 113 |
| 2015-09-30 | 113 |
| 2015-06-30 | 114 |
| 2015-03-31 | 113 |
| 2014-12-31 | 114 |
| 2014-09-30 | 114 |
| 2014-06-30 | 114 |
| 2014-03-31 | 114 |
| 2013-12-31 | 114 |
| 2013-09-30 | 113 |
| 2013-06-30 | 113 |
| 2013-03-31 | 115 |
| 2012-12-31 | 115 |
| 2012-09-30 | 115 |
| 2012-06-30 | 115 |
| 2012-03-31 | 114 |
| 2011-12-31 | 114 |
| 2011-09-30 | 113 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.338B | $2.856B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.882B | 25.03 |
| CVS Health (CVS) | United States | $122.206B | 12.19 |
| HCA Healthcare (HCA) | United States | $92.119B | 14.32 |
| Elevance Health (ELV) | United States | $92.005B | 14.44 |
| Cencora (COR) | United States | $62.254B | 19.02 |
| Natera (NTRA) | United States | $49.267B | 0.00 |
| Labcorp Holdings (LH) | United States | $25.572B | 18.03 |
| Viatris (VTRS) | United States | $19.136B | 6.61 |
| Medpace Holdings (MEDP) | United States | $16.619B | 34.90 |
| DiDi Global (DIDIY) | China | $16.275B | 178.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.114B | 0.00 |
| Solventum (SOLV) | United States | $15.290B | 12.65 |
| Charles River Laboratories (CRL) | United States | $13.038B | 27.59 |
| ICON (ICLR) | Ireland | $12.935B | 17.58 |
| BrightSpring Health Services (BTSG) | United States | $11.931B | 41.02 |
| Avantor (AVTR) | United States | $10.254B | 18.49 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| HealthEquity (HQY) | United States | $7.944B | 25.89 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.362B | 72.36 |
| PACS (PACS) | United States | $7.051B | 23.70 |
| Sonic Healthcare (SKHHY) | Australia | $6.687B | 0.00 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.355B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.282B | 23.76 |
| MiniMed (MMED) | United States | $6.181B | 0.00 |
| Sotera Health (SHC) | United States | $5.285B | 21.79 |
| Concentras Parent (CON) | United States | $4.566B | 22.52 |
| Organon (OGN) | United States | $3.585B | 4.55 |
| CareDx (CDNA) | United States | $2.709B | 308.06 |
| Alignment Healthcare (ALHC) | United States | $2.684B | 68.11 |
| GeneDx Holdings (WGS) | United States | $2.676B | 249.28 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.187B | 12.81 |
| Establishment Labs Holdings (ESTA) | United States | $2.143B | 0.00 |
| Progyny (PGNY) | United States | $2.137B | 30.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.013B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.914B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.838B | 70.20 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.607B | 0.00 |
| Ardent Health (ARDT) | United States | $1.552B | 8.87 |
| Agilon Health (AGL) | United States | $1.551B | 0.00 |
| Nutex Health (NUTX) | United States | $1.486B | 8.52 |
| InnovAge Holding (INNV) | United States | $1.470B | 0.00 |
| Omada Health (OMDA) | United States | $1.255B | 256.25 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.220B | 23.73 |
| Teladoc Health (TDOC) | United States | $1.181B | 0.00 |
| CryoPort (CYRX) | United States | $0.808B | 0.00 |
| GMR Solutions (GMRS) | United States | $0.716B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Forward Industries (FWDI) | United States | $0.513B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.474B | 0.00 |
| SBC Medicals (SBC) | United States | $0.467B | 9.66 |
| Shoulder Innovations (SI) | United States | $0.382B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.47 |
| Embecta (EMBC) | United States | $0.297B | 2.57 |
| Biodesix (BDSX) | United States | $0.289B | 0.00 |
| So-Young (SY) | China | $0.266B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.101B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.091B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.065B | 7.65 |
| Tevogen (TVGN) | United States | $0.049B | 0.00 |
| DocGo (DCGO) | United States | $0.037B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |